Pediatric Neuroblastoma Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on pediatric neuroblastoma treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for pediatric neuroblastoma treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pediatric neuroblastoma treatment market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Markets Covered:1) By Treatment Type: Immunotherapy; Chemotherapy; Radiation Therapy; Other Treatment Types
2) By Risk Group: Low Risk; Intermediate Risk; High Risk
3) By End User: Hospitals; Specialty Clinics; Other End Users
Subsegments:
1) By Immunotherapy: Monoclonal Antibodies; Immune Checkpoint Inhibitors; CAR T-Cell Therapy
2) By Chemotherapy: Alkylating Agents; Antimetabolites; Topoisomerase Inhibitors
3) By Radiation Therapy: External Beam Radiation Therapy (EBRT); Radioisotope Therapy
4) By Other Treatment Types: Surgery; Stem Cell Transplantation; Targeted Therapy
Companies Mentioned: United Therapeutics Corporation; APEIRON Biologics AG; Baxter International Inc.; Cell Ectar Biosciences Inc.; Pfizer Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
- 1. Executive Summary
- 2. Pediatric Neuroblastoma Treatment Market Characteristics
- 3. Pediatric Neuroblastoma Treatment Market Trends And Strategies
- 4. Pediatric Neuroblastoma Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
- 5. Global Pediatric Neuroblastoma Treatment Growth Analysis And Strategic Analysis Framework
- 5.1. Global Pediatric Neuroblastoma Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Pediatric Neuroblastoma Treatment Market Growth Rate Analysis
- 5.4. Global Pediatric Neuroblastoma Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Pediatric Neuroblastoma Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Pediatric Neuroblastoma Treatment Total Addressable Market (TAM)
- 6. Pediatric Neuroblastoma Treatment Market Segmentation
- 6.1. Global Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Immunotherapy
- Chemotherapy
- Radiation Therapy
- Other Treatment Types
- 6.2. Global Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Low Risk
- Intermediate Risk
- High Risk
- 6.3. Global Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals
- Specialty Clinics
- Other End Users
- 6.4. Global Pediatric Neuroblastoma Treatment Market, Sub-Segmentation Of Immunotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Monoclonal Antibodies
- Immune Checkpoint Inhibitors
- CAR T-Cell Therapy
- 6.5. Global Pediatric Neuroblastoma Treatment Market, Sub-Segmentation Of Chemotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Alkylating Agents
- Antimetabolites
- Topoisomerase Inhibitors
- 6.6. Global Pediatric Neuroblastoma Treatment Market, Sub-Segmentation Of Radiation Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- External Beam Radiation Therapy (EBRT)
- Radioisotope Therapy
- 6.7. Global Pediatric Neuroblastoma Treatment Market, Sub-Segmentation Of Other Treatment Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Surgery
- Stem Cell Transplantation
- Targeted Therapy
- 7. Pediatric Neuroblastoma Treatment Market Regional And Country Analysis
- 7.1. Global Pediatric Neuroblastoma Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Pediatric Neuroblastoma Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8. Asia-Pacific Pediatric Neuroblastoma Treatment Market
- 8.1. Asia-Pacific Pediatric Neuroblastoma Treatment Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 9. China Pediatric Neuroblastoma Treatment Market
- 9.1. China Pediatric Neuroblastoma Treatment Market Overview
- 9.2. China Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 10. India Pediatric Neuroblastoma Treatment Market
- 10.1. India Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11. Japan Pediatric Neuroblastoma Treatment Market
- 11.1. Japan Pediatric Neuroblastoma Treatment Market Overview
- 11.2. Japan Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12. Australia Pediatric Neuroblastoma Treatment Market
- 12.1. Australia Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13. Indonesia Pediatric Neuroblastoma Treatment Market
- 13.1. Indonesia Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14. South Korea Pediatric Neuroblastoma Treatment Market
- 14.1. South Korea Pediatric Neuroblastoma Treatment Market Overview
- 14.2. South Korea Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15. Western Europe Pediatric Neuroblastoma Treatment Market
- 15.1. Western Europe Pediatric Neuroblastoma Treatment Market Overview
- 15.2. Western Europe Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16. UK Pediatric Neuroblastoma Treatment Market
- 16.1. UK Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17. Germany Pediatric Neuroblastoma Treatment Market
- 17.1. Germany Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18. France Pediatric Neuroblastoma Treatment Market
- 18.1. France Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19. Italy Pediatric Neuroblastoma Treatment Market
- 19.1. Italy Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20. Spain Pediatric Neuroblastoma Treatment Market
- 20.1. Spain Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21. Eastern Europe Pediatric Neuroblastoma Treatment Market
- 21.1. Eastern Europe Pediatric Neuroblastoma Treatment Market Overview
- 21.2. Eastern Europe Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22. Russia Pediatric Neuroblastoma Treatment Market
- 22.1. Russia Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23. North America Pediatric Neuroblastoma Treatment Market
- 23.1. North America Pediatric Neuroblastoma Treatment Market Overview
- 23.2. North America Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24. USA Pediatric Neuroblastoma Treatment Market
- 24.1. USA Pediatric Neuroblastoma Treatment Market Overview
- 24.2. USA Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25. Canada Pediatric Neuroblastoma Treatment Market
- 25.1. Canada Pediatric Neuroblastoma Treatment Market Overview
- 25.2. Canada Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26. South America Pediatric Neuroblastoma Treatment Market
- 26.1. South America Pediatric Neuroblastoma Treatment Market Overview
- 26.2. South America Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27. Brazil Pediatric Neuroblastoma Treatment Market
- 27.1. Brazil Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28. Middle East Pediatric Neuroblastoma Treatment Market
- 28.1. Middle East Pediatric Neuroblastoma Treatment Market Overview
- 28.2. Middle East Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29. Africa Pediatric Neuroblastoma Treatment Market
- 29.1. Africa Pediatric Neuroblastoma Treatment Market Overview
- 29.2. Africa Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 30. Pediatric Neuroblastoma Treatment Market Competitive Landscape And Company Profiles
- 30.1. Pediatric Neuroblastoma Treatment Market Competitive Landscape
- 30.2. Pediatric Neuroblastoma Treatment Market Company Profiles
- 30.2.1. United Therapeutics Corporation Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. APEIRON Biologics AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Cell Ectar Biosciences Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 31. Pediatric Neuroblastoma Treatment Market Other Major And Innovative Companies
- 31.1. MacroGenics Inc.
- 31.2. Bayer AG
- 31.3. Provectus Biopharmaceuticals Inc.
- 31.4. Sartorius AG
- 31.5. Y-mAbs Therapeutics Inc.
- 31.6. Amgen Inc.
- 31.7. Eli Lilly and Company
- 31.8. F. Hoffmann-La Roche AG
- 31.9. Clarity Pharmaceuticals
- 31.10. CureSearch for Children's Cancer
- 31.11. Novartis AG
- 31.12. Johnson & Johnson Services Inc.
- 31.13. AbbVie Inc.
- 31.14. Merck & Co. Inc.
- 31.15. Bristol-Myers Squibb Company
- 32. Global Pediatric Neuroblastoma Treatment Market Competitive Benchmarking And Dashboard
- 33. Key Mergers And Acquisitions In The Pediatric Neuroblastoma Treatment Market
- 34. Recent Developments In The Pediatric Neuroblastoma Treatment Market
- 35. Pediatric Neuroblastoma Treatment Market High Potential Countries, Segments and Strategies
- 35.1 Pediatric Neuroblastoma Treatment Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Pediatric Neuroblastoma Treatment Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Pediatric Neuroblastoma Treatment Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
- 36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook